Evidence map›Paper›PMID 28412746›Full record

ArticleOncotarget2017

Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions.

Miguel F Segura, Luz Jubierre, SiDe Li, Aroa Soriano, Lisa Koetz, Avital Gaziel-Sovran, Marc Masanas, Kevin Kleffman, John F Dankert, Martin J Walsh and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Miguel F SeguraDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Luz JubierreLaboratory of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain.
SiDe LiDepartments of Structural and Chemical Biology, Genetics and Genomic Sciences and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Aroa SorianoLaboratory of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain.
Lisa KoetzDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Avital Gaziel-SovranDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Marc MasanasLaboratory of Translational Research in Child and Adolescent Cancer, Vall d'Hebron Research Institute (VHIR)-UAB, Barcelona, Spain.
Kevin KleffmanDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
John F DankertDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Martin J WalshDepartments of Structural and Chemical Biology, Genetics and Genomic Sciences and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Eva HernandoDepartment of Pathology, New York University School of Medicine, New York, NY, USA.
Eastern Cooperative Oncology Group · USVall d'Hebron Institut de Recerca · ESIcahn School of Medicine at Mount Sinai · US

Funding

Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and MelanomaR01CA155234 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HERNANDO, EVA · 2012 to 2016
$1.9M
NCI NIH HHS R01 CA155234
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are a class of endogenous non-coding small RNAs that post-transcriptionally control the translation and stability of target mRNAs in a sequence-dependent manner. MiRNAs are essential for key cellular processes including proliferation, differentiation, cell death and metabolism, among others. Consequently, alterations of miRNA expression contribute to developmental defects and a myriad of diseases.The expression of miRNAs can be altered by several mechanisms including gene copy number alterations, aberrant DNA methylation, defects of the miRNA processing machinery or unscheduled expression of transcription factors. In this work, we sought to analyze the regulation of the miR-182 cluster, located at the 7q32 locus, which encodes three different miRNAs that are abundantly expressed in human embryonic stem cells and de-regulated in cancer. We have found that the Krüppel-like factor 4 (KLF4) directly regulates miR-182 cluster expression in human embryonic stem cells (hESCs) and in melanoma tumors, in which the miR-182 cluster is highly expressed and has a pro-metastatic role. Furthermore, higher KLF4 expression was found to be associated with metastatic progression and poor patient outcome. Loss of function experiments revealed that KLF4 is required for melanoma cell maintenance. These findings provide new insights into the regulation of the miR-182 cluster expression and new opportunities for therapeutic intervention in tumors in which the KLF4-miR-182 cluster axis is deregulated.

Indexed as

Disease SusceptibilityGene Expression RegulationMultigene FamilyCell MovementCell SurvivalDNA MethylationEmbryonic Stem CellsGene SilencingHistone Deacetylase InhibitorsHistonesHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsMelanomaMicroRNAsPromoter Regions, GeneticHistone Deacetylase InhibitorsHistonesKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsMicroRNAsembryonic stem cellsKLF4melanomamicroRNAmiR-183~96~182 cluster

Identifiers

PMID28412746
PMCPMC5432258
OpenAlexW2590468150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.